Brief depression screening with the PHQ-2 associated with prognosis following percutaneous coronary intervention with paclitaxel-eluting stenting.
about
Psychodynamic Motivation and Training program (PMT) for the secondary prevention in patients with stable coronary heart disease: study protocol for a randomized controlled trial of feasibility and effectsModifiable factors associated with sleep dysfunction in adults with heart failure.Clinical and scientific progress related to the interface between cardiology and psychology: lessons learned from 35 years of experience at the Thoraxcenter of the Erasmus Medical Center in Rotterdam.Depressive symptom severity and mortality in older adults undergoing percutaneous coronary interventionAssociation between psychological measures and brain natriuretic peptide in heart failure patients.Pre-implantation implantable cardioverter defibrillator concerns and Type D personality increase the risk of mortality in patients with an implantable cardioverter defibrillator.Psychological distress in patients with a left ventricular assist device and their partners: an exploratory study.Effects of Gender-Specific Differences, Inflammatory Response, and Genetic Variation on the Associations Among Depressive Symptoms and the Risk of Major Adverse Coronary Events in Patients With Acute Coronary Syndrome.Sensitivity and specificity of Urdu version of the PHQ-9 to screen depression in patients with coronary artery disease.Relevance of depression for anticoagulation management in a routine medical care setting: results from the ThrombEVAL study program.Transient impact of baseline depression on mortality in patients with stable coronary heart disease during long-term follow-up.Poor health status and distress in cardiac patients: the role of device therapy vs. underlying heart disease.Effectiveness of a comprehensive interactive eHealth intervention on patient-reported and clinical outcomes in patients with an implantable cardioverter defibrillator [ACQUIRE-ICD trial]: study protocol of a national Danish randomised controlled tri
P2860
Q30557010-944EF54C-38AD-4CD0-BDAB-A9AA1E266C9BQ35019519-46A78808-78CB-4CC5-9323-B3B5D6682356Q35473611-A9BD51A8-9CB7-488D-BBE5-83F4E784954BQ37409814-4A8AFBF2-FB26-4788-AEBA-B0DD0D1DA3D6Q43536866-D0570712-7FC4-4F0F-ABEE-5DD0D443A012Q44423380-1336D5D6-18C4-41CE-B233-F26E9E4B61EFQ44489481-6FDDA886-B3F5-4CA5-A4E2-11FC955977A9Q47234847-CEE2A85D-95BC-4214-874B-828B15B23E2EQ47992092-B162BC85-6B07-4AEF-9318-51B89ACB3F29Q48063492-578B1BF8-2050-4941-9F0C-A4563F75DFD5Q48364191-C0B0003D-1175-4B4D-BA1F-D2A9652EEDEBQ48609541-5519D32F-C7E0-4A93-9B14-8CDDC9312B83Q55517959-B413E934-8906-4088-BE33-EFEAFD9D80DF
P2860
Brief depression screening with the PHQ-2 associated with prognosis following percutaneous coronary intervention with paclitaxel-eluting stenting.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Brief depression screening wit ...... h paclitaxel-eluting stenting.
@en
Brief depression screening wit ...... h paclitaxel-eluting stenting.
@nl
type
label
Brief depression screening wit ...... h paclitaxel-eluting stenting.
@en
Brief depression screening wit ...... h paclitaxel-eluting stenting.
@nl
prefLabel
Brief depression screening wit ...... h paclitaxel-eluting stenting.
@en
Brief depression screening wit ...... h paclitaxel-eluting stenting.
@nl
P2093
P2860
P50
P1476
Brief depression screening wit ...... h paclitaxel-eluting stenting.
@en
P2093
Cihan Simsek
Peter de Jonge
Ron T van Domburg
P2860
P2888
P304
P356
10.1007/S11606-009-1054-1
P577
2009-07-05T00:00:00Z